Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Net Income towards Common Stockholders: 2009-2019

Historic Net Income towards Common Stockholders for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2019 value amounting to $37.0 million.

  • Neurocrine Biosciences' Net Income towards Common Stockholders rose 139.06% to $22.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $39.3 million, marking a year-over-year decrease of 57.93%. This contributed to the annual value of $37.0 million for FY2019, which is 75.32% up from last year.
  • According to the latest figures from FY2019, Neurocrine Biosciences' Net Income towards Common Stockholders is $37.0 million, which was up 75.32% from $21.1 million recorded in FY2018.
  • Over the past 5 years, Neurocrine Biosciences' Net Income towards Common Stockholders peaked at $37.0 million during FY2019, and registered a low of -$142.5 million during FY2017.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was $21.1 million (2018), whereas its average is -$28.1 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 52.90% in 2016, then spiked by 114.81% in 2018.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' Net Income towards Common Stockholders stood at -$92.3 million in 2015, then plummeted by 52.90% to -$141.1 million in 2016, then dropped by 1.03% to -$142.5 million in 2017, then spiked by 114.81% to $21.1 million in 2018, then skyrocketed by 75.32% to $37.0 million in 2019.